Skip to main content
Download PDF

Physical exercise during exposure to 40-Hz light flicker improves cognitive functions in the 3xTg mouse model of Alzheimer’s disease

Alzheimer's Research & Therapy volume 12, Article number: 62 (2020) Cite this article

Abstract

Background

Exercise promotes brain health and improves cognitive functioning in the elderly, while 40-Hz light flickering through the visual cortex reduces amyloid beta (Aβ) by stabilizing gamma oscillation. We examined whether exercise was associated with hippocampus-mediated improvement in cognitive functioning in the 3xTg-Alzheimer’s disease (3xTg-AD) murine model following exposure to 40-Hz light flickering and exercise.

Methods

We subjected 12-month-old 3xTg-AD mice to exercise and 40-Hz light flickering for 3 months to investigate spatial learning, memory, long-term memory, Aβ levels, tau levels, mitochondrial functioning including Ca2+ retention and H2O2 emission, apoptosis, and neurogenesis in the hippocampus.

Results

Treatments had a positive effect; however, the combination of exercise and 40-Hz light flickering exposure was most effective in reducing Aβ and tau levels. Reducing Aβ and tau levels by combination of exercise and 40-Hz light flickering improves Ca2+ homeostasis and reactive oxygen species such as H2O2 in mitochondria and apoptosis including bax, bcl-2, cytochrome c, and cleaved caspase-3 and cell death, cell differentiation, and neurogenesis in the 3xTg-AD model of the hippocampus, resulting in improving cognitive impairment such as spatial learning, memory and long term memory.

Conclusion

Our results show that exercising in a 40-Hz light flickering environment may improve cognitive functioning by reducing Aβ and tau levels, thereby enhancing mitochondrial function and neuroplasticity.

Background

Alzheimer’s disease (AD) is the most common degenerative brain disease. AD causes dementia, whose progressive onset leads to a gradual worsening of cognitive functioning, including memory. In the initial stages of AD, problems with memory related to recent events occur with alterations in cognitive function such as language ability and judgment, which eventually lead to the complete loss of motor function. AD accounts for > 70% of all dementia cases [1]. AD is associated with various cellular changes in the brain, including synaptic alterations, mitochondrial structural and functional changes, abnormal inflammatory responses, extracellular amyloid beta (Aβ) accumulation, and intracellular neurofibrillary tangles [2,3,4]. In particular, it is known that Aβ is directly correlated with AD pathology and that longer isoforms with 42–43 residues (the smaller isoform has 40 residues) cause neurodegeneration and cognitive dysfunction, eventually progressing to dementia [5, 6]. Reduced Aβ clearance or Aβ overproduction may cause Aβ accumulation in subcellular compartments, including synapses and mitochondria, and may impair organelle and ultimately neuronal function [7,8,9].

AD is caused by hippocampal atrophy, which is involved in memory and learning, the presence of senile plaques, and the accumulation of hyperphosphorylated aggregates of tau protein [10, 11]. Overexpression or hyperphosphorylation of tau protein due to AD impairs axonal migration of organelles including the mitochondria [12, 13]. There is substantial evidence suggesting that mitochondrial dysfunction is associated with aging and neurodegenerative diseases. Reduced mitochondrial function has been demonstrated using AD transgenic mouse models as well as post-mortem brain tissue of patients with AD [14, 15], fibroblasts, and blood cells [16,17,18]. Mitochondrial dysfunction participates in the progression of AD and is present in all stages of the disease. It has been suggested that AD is not limited to the brain but could be a systemic disease [16].

In the brain, gamma oscillation occurs between 25 and 145 Hz, affecting various behavioral functions such as attention and memory [19]. This is disrupted in animal models and clinical studies of AD and other disorders [20,21,22]. Specifically, in the brains of AD patients, gamma rhythms are known to be interrupted and Aβ has been suggested as the potential cause, particularly in the hippocampus [23]. Aβ accumulation affects memory through the inhibition of electrical signaling such as gamma oscillations, which play an important role in cognitive functioning and sensory response [24,25,26]. The wavelength, duration, and intensity of light exposure regulate the cognitive tasks that the brain responds to, and these light responses have been observed in subcortical areas, such as the hypothalamus, the brain stem, and the thalamus, as well as in limbic areas including the amygdala and the hippocampus [27]. According to Naeser et al. [28], cognitive function is improved through light-emitting diode (LED) therapy in patients with chronic traumatic brain injury. In addition, previous studies have consistently reported that exercise is beneficial to brain functioning and is a primary method of preventing and treating AD in combination with drugs. However, unlike certain drugs that target localized causes, the positive effects of exercise mitigate or delay multiple aspects related to AD. In animal studies using familial AD gene mutations, exercise was reported to minimize neurotoxicity caused by AD neuropathy and stimulate neuronal regeneration, contributing to an improvement in cognitive functioning through a reduction in beta-secretase activity [29], decreased accumulation of amyloid plaques and soluble Aβ [30, 31], and decreased pTau [32]. Therefore, this study aimed to examine the effects of exercise training in a 40-Hz light flicker environment on Aβ accumulation in the hippocampus, Akt/tau, mitochondrial function, neuroplasticity, and cognitive functioning in an AD animal model.

Methods

Animals

All animal experiments were performed in accordance with the guidelines of the National Institutes of Health and the Korean Academy of Medical Science. The study protocol was approved by the KyungHee University Institutional Animal Care and Use Committee (approval number KHUASP [SE]-17-103). The mice were housed under conditions of controlled temperature (25 ± 1 °C) and lighting (7 am to 7 pm) with food and water ad libitum. Fifteen-month-old male wild-type and 3xTg mice were randomly divided into a wild-type control group (CON), a 3xTg-AD group (AD), a 3xTg-AD and 40-Hz light flickering group (AD+40), a 3xTg-AD and Exercise group (AD+EX), and a 3xTg and exercise under 40-Hz light flickering group (AD+40+EX) (n = 10 in each group). We used the 3xTg-AD mice harboring APP Swe, PS1M146V, and tau P301L human transgenes. The genotype was confirmed by PCR analysis of DNA obtained by tail biopsies. BrdU (Sigma, St. Louis MO, USA) was administered intraperitoneally (i.p.) at 100 mg/kg/day for 7 days, and we sacrificed the mice 4 weeks after first day of BrdU injection to observe neurogenesis.

Exercise protocol and 40-Hz light flickering of exposure time

Exercise sessions began at age 12 months of 3xTg mice. The exercise groups exercised on a treadmill made for animal use once daily in the dark, 6 days per week for 12 consecutive weeks. For exercises of adaption, mice were allowed 5 min of warm up at a 0° inclination at 3 m/min, 30 min of the main exercise at 10 m/min, and 5 min of cool down at 3 m/min which were performed for the first 3 weeks. Subsequently, mice were subjected to 40 min of the main exercise at 11 m/min for weeks 4 to 6, 50 min of the main exercise at 12 m/min for weeks 7 to 9, and 50 min of the main exercise at 13 m/min for the final weeks 10 to 12. Exposure time of 40-Hz light flickering was the same as exercise time.

Behavioral tests

Morris water maze

The Morris water maze task was used to assess spatial learning and working memory. One day before training, the mice were habituated to swimming for 60 s in the pool without a platform. All mice were trained three times per day for five consecutive days. A probe trial was performed 24 h after the final training session. When a mouse found the platform, it was allowed to remain there for 30 s. If the mouse did not find the platform within 60 s, it was guided by hand to the platform. The mice underwent a 60-s retention probe test, after which the platform was removed from the pool. The data were automatically collected using the Smart Video Tracking System (Smart version 2.5, Panlab, Barcelona, Spain).

Step through avoidance test

The step through avoidance task was used to assess long-term memory. For the training period, the mouse was placed at the entrance identified by the halogen bulbs and the door of the box was opened. When the mouse entered the dark place, the door and the mouse were allowed to stay for 20 s. This training was repeated twice. Finally, during the third training session, when the mouse entered the dark place, the door closed at the same time and the mouse received a 1-mA scramble foot shock for 2 s. After 24 h of the foot shock, mice were placed back at the entrance identified by the halogen bulb, and when the door opened, the time taken for mice to enter the dark place was measured. A latency time > 300 s was counted as 300 s.

Preparation of tissue

The mice were euthanized immediately after the behavior test. To prepare the brain slices, the animals were fully anesthetized with ethyl ether, perfused transcardially with 50 mM phosphate-buffered saline (PBS), and then fixed with a freshly prepared solution of 4% paraformaldehyde in 100 mM phosphate buffer (pH 7.4). The brains were then removed, post-fixed in the same fixative overnight, and transferred into a 30% sucrose solution for cryoprotection. Coronal sections with a thickness of 40 μm were created using a freezing microtome (Leica, Nussloch, Germany). From each group of 10 animals, 5 were used for immunohistochemistry and 5 for western blot and mitochondrial function analysis. The hippocampal tissue for western blot analysis was immediately stored at − 70 °C until use. For immunohistochemistry, 2 sections from each group were analyzed, resulting in a total of 10 slices.

Immunohistochemistry

To visualize cell differentiation, immunohistochemistry was performed for DCX staining in the dentate gyrus (DG) and Aβ in CA1 to 3 and in the DG hippocampus. The sections were incubated in PBS for 10 min and then washed three times for 3 min in the PBS. The sections were then incubated in 1% H2O2 for 15 to 30 min. The sections were selected from each brain and incubated overnight with goat anti-DCX antibody (1:500; Santa Cruz) and mouse purified anti-β-amyloid antibody (1:200; Biolegend) and then with biotinylated rabbit secondary antibody (1:250; Vector Laboratories) for another 90 min. The secondary antibody was amplified with the Vector Elite ABC Kit® (1100; Vector Laboratories). Antibody-biotin-avidin-peroxidase complexes were visualized using the 3,3,diaminobenzidine (DAB) substrate kit (Vector Laboratories). The slides were air-dried overnight at room temperature, and the coverslips were mounted using Permount®.

Immunofluorescence

BrdU/NeuN-positive cells in the DG were tested for immunofluorescence. In brief, the brain sections were permeabilized by incubation in 0.5% Triton X-100 in PBS for 20 min, incubated in 50% formamide-2× standard saline citrate at 65 °C for 2 h, denatured in 2 N HCl at 37 °C for 30 min, and then rinsed twice in 100 mM sodium borate (pH 8.5), in that order. The sections were incubated overnight with rat anti-BrdU antibody (1:200; Abcam, Cambridge, UK) and mouse anti-NeuN antibody (1:200; Millipore, Temecula, CA). The brain sections were then washed in PBS and incubated with the appropriate secondary antibodies for 1 h. The secondary antibodies used were anti-mouse IgG Alexa Fluor-488 and anti-rat IgG Alexa Fluor-560. Images were captured using an FV3000 confocal microscope (Olympus, Tokyo, Japan).

TUNEL staining

To visualize DNA fragmentation, we performed TUNEL staining using an In Situ Cell Death Detection Kit (Roche Diagnostics, Risch-Rotkreuz, Switzerland) according to the manufacturer’s protocol. Sections were post-fixed in ethanol-acetic acid (2:1), rinsed, incubated with proteinase K (100 mg/mL), and then rinsed again. Next, they were incubated in 3% H2O2, permeabilized with 0.5% Triton X-100, rinsed again, and incubated in the TUNEL reaction mixture. The sections were rinsed and visualized using Converter-POD with 0.03% DAB, counterstained with Cresyl violet, and mounted onto gelatin-coated slides. The slides were air-dried overnight at room temperature and cover-slipped using Permount mounting medium.

Western blotting

Hippocampal tissues were homogenized on ice and lysed in lysis buffer containing 50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 0.5% deoxycholic acid, 1% Nonidet P40, 0.1% sodium dodecyl sulfate, 1 mM PMSF, and leupeptin 100 mg/mL. The protein content was measured using a colorimetric protein assay kit (Bio-Rad, Hercules, CA). Thirty micrograms of protein was separated on sodium dodecyl sulfate-polyacrylamide gels and transferred onto a nitrocellulose membrane, which was incubated with mouse β-actin (1:1000; Santa Cruz Biotechnology), GAPDH (1:3000; Santa Cruz Biotechnology), t-Akt and p-Akt (1:1000; Cell Signaling), t-GSK3β and p-GSK3β (ser 9) (1:1000; Cell Signaling), t-Tau and p-Tau (ser202/Thr205 (1:1000; Thermo Fisher), Bcl-2 and cytochrome C (1:1000; Santa Cruz Biotechnology), Bax (1:1000; Cell Signaling), cleaved caspase-3 (1:700; Cell Signaling), brain-derived neurotrophic factor (BDNF; 1:1000; Alomone), PSD95 (1:1000; Cell Signaling), and synaptophysin (1:1000; Abcam) primary antibodies. Horseradish peroxidase-conjugated secondary anti-mouse antibodies were used for Bcl-2, p-Tau, cytochrome C, β-actin, and GAPDH; anti-rabbit conjugated secondary antibodies were used for t-Akt, p-Akt, t-tau, p-tau, t-GSK3β, Bax, cleaved caspase-3, BDNF, PSD95, and synaptophysin.

Mitochondrial Ca2+ retention capacity

The mitochondrial calcium retention capacity was tested to assess the susceptibility of the permeability transition pore (PTP) to opening. Briefly, after grinding the hippocampal tissue, overlaid traces of changes in fluorescence induced by Calcium Green-5 N were measured continuously (ΔF/min) at 37 °C during state 4 respiration using a Spex FluoroMax 4 spectrofluorometer (Horiba Scientific, Edison, NJ). After establishing the background ΔF (hippocampal tissue in the presence of 1 μM is Calcium Green-5N, 1 U/mL hexokinase, 0.04 mM EGTA, 1.5 nM thapsigargin, 5 mM 2-deoxyglucose, 5 mM glutamate, 5 mM succinate, and 2 mM malate), the reaction was initiated by addition of Ca2+ pulses (12.5 nM), with excitation and emission wavelengths set at 506 nm and 532 nm, respectively. The total mitochondrial Ca2+ retention capacity prior to PTP opening (i.e., release of Ca2+) was expressed as pmol/mg tissue weight.

Mitochondrial H2O2 emission

H2O2 emission was measured at 37 °C (ΔF/min) during state 4 respiration (10 μg/ml oligomycin) by continuously monitoring oxidation of Amplex Red (excitation/emission λ = 563/587 nm) using a Spex FluoroMax 4 spectrofluorometer with the following protocol: 10 μM Amplex Red, 1 U/mL horseradish peroxidase, and 10 μg/mL oligomycin settings and 1 mM malate + 2 mM glutamate (complex I substrates), 3 mM succinate (complex II substrate), and 10 mM glycerol-3-phosphate (lipid substrate). The H2O2 emission rate after removing the background value from each of the standard values (standard curve) was calculated from the ΔF/min gradient values and expressed as pmol/min/mg tissue weight.

Statistical analysis

Spatial learning was measured by two-way mixed analysis of variance to account for repeated measures (5 groups; between × 5 days repeated; within). Cell counting and optical density quantification for Aβ, TUNEL, DCX, and BrdU/NeuN-positive cells’ expression were performed using Image-Pro® Plus (Media Cyberbetics Inc.) attached to a light microscope (Olympus, Tokyo, Japan). The data were analyzed with one-way ANOVA, followed by the Duncan post hoc tests. All values are expressed as the mean ± standard error of the mean (S.E.M.), and P values < .05 were considered significant.

Results

Effect of exercise under exposure to the 40-Hz light flickering on spatial working learning and memory and long-term memory

The Morris water maze and step through avoidance task were performed to assess spatial learning and memory and long-term memory. Spatial learning was assessed as the time spent on the platform. In the two-way mixed ANOVA accounting for the repeated measures of spatial learning, results are presented as the outcome of a multivariate test. During the Morris water maze task, there was a significant interaction between the repeated measure and group (day; p = .000, day × group; p = .000). Over time, the effect of repeated learning had differential effects on the groups. Particularly, significant decreases in the time taken to find the platform in spatial learning capability during the Morris water maze task were observed from days 3 to 5 of training in the AD+EX, AD+40, and AD+40+EX groups: day 1, CON vs AD (P = .027); day 2, CON vs AD (P = .000), CON vs AD+40 (P = .019), CON vs AD+EX (P < .001), and AD vs AD+40+EX (P = .019); day 3, CON vs AD (P = .003), AD vs AD+40 (P = .004), AD vs AD+EX (P = .015), and AD vs AD+40+EX (P < .001); day 4, CON vs AD (P < .001), AD+40 (P < .001), AD vs AD+EX (P = .001), and AD vs AD+40+EX (P = .000); and day5, CON vs AD (P < .001), AD vs AD+40 (P < .001), AD vs AD+EX (P = .003), and AD vs AD+40+EX (P < .001). In the AD group, the implementation of exercise and 40-Hz light flickering was effective in the repetitive learning, especially the combination of 40-Hz light flickering and exercise. Spatial memory (P < .001) and long-term memory (P < .001) were significantly reduced in the AD group compared with the CON group. In contrast, spatial memory and long-term memory were enhanced by exposure to AD+40-Hz (P = .008, P = .030), AD+EX (P = .001, P = .019), and AD+40+EX (P < .001 respectively). Groups of treatment comparison revealed significant differences for spatial learning and long-term memory between AD+40+EX and AD+40 (p < .001, p = .001, respectively) and AD+EX (P = .007, P = .002, respectively) groups. AD+40 and AD+EX groups did not show a significant intergroup difference. Therefore, it is worth noting that exercise was most effective in improving cognitive functioning under the 40-Hz light flickering condition in AD and that the results were better than the normal aging group used as CON (Fig. 1, Table 1).

Fig. 1
figure1

Effects of exercise under exposure to the 40-Hz light flicker on spatial learning and memory and long-term memory. The Morris water maze task for spatial learning (a) and memory (b) and step through task for long-term memory (c). CON: wild-type, AD: 3xTg-AD, AD+40: 3xTg-AD and 40-Hz light flickering, AD+EX: 3xTg-AD and exercise, and AD+40+EX: 3xTg-AD and exercise in the 40-Hz light flickering group. Data are expressed as the mean ± standard error of the mean (SEM). *P < .05 compared to the CON group. #P < .05 compared to the AD group. +P < .05 compared to the AD+40+EX. $P < .05 for a difference between the group because of the interaction effect

Full size image
Table 1 Effect of exercise under exposure to the 40-Hz light flickering on spatial learning and memory and long-term memory
Full size table

Effects of exercise under exposure to 40-Hz light flickering on Aβ in the hippocampus

The number of Aβ-positive cells in the CA1, CA2–3, and DG of the hippocampus was significantly decreased in the AD group compared with the treatment groups; Aβ-positive cells were reduced in the AD+40 (CA1: P < .001, CA2–3: P < .001, DG: P < .001), AD+EX (CA1: P < .001, CA2–3: P < .001, DG: P < .001), and AD+40+EX (CA1: P < .001, CA2–3: P < .001, DG: P < .001) groups. When exercise alone was compared with exercise performed under the 40-Hz light flickering condition, the AD+40+EX group showed an intergroup difference when compared to AD+40 (P < .001) and AD+EX (P < .001) across all areas of the hippocampus (CA1, CA2–3, and DG); however, groups exposed to 40-Hz light flickering or exercise alone (AD+40 and AD+EX groups, respectively) did not show any significant intergroup difference. Therefore, each method was effective in removing Aβ, although performing exercise under the 40-Hz light flickering condition was the most efficacious. It is interesting to note that exercise during the 40-Hz light flickering condition reduced Aβ to CON levels in the CA2–3 and DG of the hippocampus (Fig. 2, Table 2).

Fig. 2
figure2

Effects of exercise under exposure to the 40-Hz light flicker on Aβ in the hippocampus. Photomicrographs and data of Aβ-positive cells. The scale bar represents 50 μm. AD: 3xTg-AD, AD+40: 3xTg-AD and 40-Hz light flickering, AD+EX: 3xTg-AD and exercise, and AD+40+EX: 3xTg-AD and exercise in the 40-Hz light flickering. Data are expressed as the mean ± standard error of the mean (SEM). *P < .05 compared to the AD group. +P < .05 compared to the AD+40+EX

Full size image
Table 2 Effect of exercise under exposure to the 40-Hz light flickering on Aβ in the hippocampus
Full size table

Effects of exercise under exposure to the 40-Hz light flickering on Akt/tau in the hippocampus

Western blot was used to analyze the changes in expression of Akt/tau proteins in the hippocampus. For an intergroup comparison, the ratio of the CON group was set to 1 and a comparison was made with the relative value of each group. When the CON group was compared to the AD group, the p-Akt/Akt ratio (P < .001) and p-GSK3β/GSK3β ratio (P < .001) were reduced while the p-tau/tau ratio (P < .001) increased. In contrast, when the AD group was compared to the treatment groups, the p-Akt/Akt ratio and p-GSK3β/GSK3β ratio of protein expression were increased: AD+40 (p-Akt/Akt ratio: P < .001, p-GSK3β/GSK3β ratio: P = .003), AD+EX (p-Akt/Akt ratio: P < .001, p-GSK3β/GSK3β ratio: P = .001), and AD+40+EX (p-Akt/Akt ratio: P < .001, p-GSK3β/GSK3β ratio: P < .001). The p-Tau/tau ratio expression was significantly reduced in AD+40 (P = .026), AD+EX (P = .001), and AD+40+EX (P < .001). When a comparison was made among treatment groups, AD+40+EX showed an intergroup difference with AD+40 (P = .026) and AD+EX (p < 0.001), while there was no difference between AD+40 and AD+EX groups. In other words, 40-Hz light flickering and exercise were both effective in reducing the Akt/tau protein ratio when administered alone, but exercise under the exposure to 40-Hz light flickering was even more effective, reducing the level to that of the CON group. The p-Akt/Akt and p-GSK3β/GSK3β ratios were also significantly increased compared to the CON group (Fig. 3, Table 3).

Fig. 3
figure3

Effects of exercise under exposure to the 40-Hz light flicker on p-Akt/t-Akt, p-GSK3β/t-GSK3β, and p-tau/t-tau ratio in the hippocampus. CON: wild-type, AD: 3xTg-AD, AD+40: 3xTg-AD and 40-Hz light flickering, AD+EX: 3xTg-AD and exercise, and AD+40+EX: 3xTg-AD and exercise in the 40-Hz light flickering. Data are expressed as the mean ± standard error of the mean (SEM). *P < .05 compared to the CON group. #P < .05 compared to the AD group. +P < .05 compared to the AD+40+EX

Full size image
Table 3 Effect of exercise under exposure to the 40-Hz light flickering on Akt/Tau in the hippocampus
Full size table

Effects of exercise under exposure to the 40-Hz light flickering on Ca2+ retention and H2O2 production in the hippocampus

Mitochondrial Ca2+ retention capacity in the hippocampus was reduced in the AD group when compared with the CON group (P < .001). In contrast, when the AD group was compared to the treatment groups, AD+40 (P = .006), AD+EX (P < .001), and AD+40+EX (P < .001) showed increased mitochondrial Ca2+ retention capacity. An intergroup comparison revealed an intergroup difference between the AD+40 (P < .001) and AD+EX (P < .001) groups, while the AD+40 and AD+EX groups did not show any significant difference. The mitochondrial H2O2 production rate was calculated using the complex I substrate (glutamate + malate, GM), the complex 2 substrate (succinate, GMS), and the lipid substrate (glycerol-3 phosphate, GMSG3P). The mitochondrial H2O2 production rate in the hippocampus was significantly increased compared with the CON group (GM: P = .007, GMS: P < .001, GMSG3P: P < .001). In contrast, when the AD group was compared to the treatment groups, H2O2 production was significantly reduced in the AD+40 (GM: P = .027, GMS: P < .001, GMSG3P: P = .005), AD+EX (GM: P = .034, GMS: P < .001, GMSG3P: P = .003), and AD+40+EX (GM: P = .019, GMS: P < .001, GMSG3P: P < .001) groups. In the intergroup comparisons, the GM did not show a difference among the treatment groups, but a significant difference was observed for GMS and GMSG3P expression between the AD+40+EX and AD+40 (P = .025, P = .005, respectively) and AD+EX groups (P = .012, P = .009, respectively). However, AD+40 and AD+EX groups did not show any significant difference. Thus, exercise under exposure to 40-Hz light flickering appeared to be the most effective in improving mitochondrial function in the hippocampus by maintaining mitochondrial Ca2+ retention and reducing ROS. These levels were recovered to normal levels as in the CON group (Fig. 4, Table 4).

Fig. 4
figure4

Effects of exercise under exposure to the 40-Hz light flicker on mitochondrial functions in the hippocampus. Control (CON): wild-type, AD: 3xTg-AD, AD+40: 3xTg-AD and 40-Hz light flickering, AD+EX: 3xTg-AD and exercise, and AD+40+EX: 3xTg-AD and exercise in the 40-Hz light flickering. Data are expressed as the mean ± standard error of the mean (SEM). *P < .05 compared to the CON group. #P < .05 compared to the AD group. +P < .05 compared to the AD+40+EX

Full size image
Table 4 Effect of exercise under exposure to the 40-Hz light flickering on Ca2+ retention and H2O2 in the hippocampus
Full size table

Effects of exercise under exposure to the 40-Hz light flickering on apoptosis and cell death in the hippocampus

In order to examine the changes in apoptosis in the hippocampus, we analyzed cell death using TUNEL-positive cells and the expression of Bax, Bcl-2, cytochrome C, and cleaved caspase-3 proteins. For intergroup comparison of apoptosis, the value of the CON group was set to 1 and compared with the relative value of each group. When the CON and AD groups were compared, the expression of Bax (P < .001), cytochrome C (P = .001), and cleaved caspase-3 (P < .001) increased, while Bcl-2 (P < .001) was reduced. In contrast, when the AD group was compared with the treatment groups, significant differences were observed with the following treatment groups: AD+40 (Bax: P = .001, Bcl-2: P = .009, cytochrome C: P = .038, cleaved caspase-3P = .002), AD+EX (Bax: P = .001, Bcl-2: P = .002, cytochrome c: P = .013, cleaved caspase-3: P < .001), and AD+40+EX (P < .001 respectively). In the comparison among the treatment groups, AD+40+EX was significantly different from AD+40 (Bax, Bcl-2, cytochrome C, cleaved caspase-3, P < .001 each) and AD+EX exposure (Bax, Bcl-2, cytochrome c, cleaved caspase-3, P < .001 each), while AD+40 and AD+EX did not show an intergroup difference. When the TUNEL-positive cells of the hippocampus were compared, the AD group showed a significant increase compared to the CON group (P < .001). In contrast, when the AD group was compared with the treatment groups, a reduction was observed in the AD+40 (P < .001), AD+EX (P < .001), and AD+40+EX (P < .001) treated groups. When the treatment groups were compared among themselves, an intergroup difference was observed for AD+40+EX from AD+40 (P = .001) and AD+EX (P = .001) while AD+40 and AD+EX groups did not show an intergroup difference. Therefore, exercise under the exposure to 40-Hz light flickering was the most effective in decreasing apoptosis and cell death in the hippocampus, and this was restored to levels observed in the CON group (Fig. 5, Table 5).

Fig. 5
figure5

Effects of exercise under exposure to the 40-Hz light flicker on apoptosis and cell death in the hippocampus. Photomicrographs and data of TUNEL-positive cells. The scale bar represents 50 μm. Control (CON): wild-type, AD: 3xTg-AD, AD+40: 3xTg-AD and 40-Hz light flickering, AD+EX: 3xTg-AD and exercise, and AD+40+EX: 3xTg-AD and exercise in the 40-Hz light flickering. Data are expressed as the mean ± standard error of the mean (SEM). *P < .05 compared to the CON group. #P < .05 compared to the AD group. +P < .05 compared to the AD+40+EX

Full size image
Table 5 Effect of exercise under exposure to the 40-Hz light flickering on apoptosis and cell death in the hippocampus
Full size table

Effects of exercise under exposure to the 40-Hz light flickering on BDNF, PSD95, and synaptophysin in the hippocampus

To examine changes in synaptic proteins in the hippocampus, the expression of BDNF, PSD 95, and synaptophysin were examined. For intergroup comparison, the value of the CON group was set to 1, which was compared to the relative value of each group. When the CON group was compared with the AD group, the expression of BDNF, PSD 95, and synaptophysin was reduced (P < .001 respectively). In contrast, when the AD group was compared with the treatment groups, AD+40 (BDNF: P = .024, PSD95: P = .002, synaptophysin: P < .001), AD+EX (BDNF: P = .005, PSD95: P = .001; synaptophysin: P < .001), and AD+40+EX (P < .001 respectively) groups showed a significant increase. In the comparison among treatment groups, AD+40+EX showed a significant difference in AD+40 and AD+EX (P < .001, respectively), while AD+40 and AD+EX treatments did not show any significant differences. Therefore, exercise under the exposure to 40-Hz light flickering was the most effective in improving the level of proteins associated with hippocampal synapses. In particular, the level of expression of BDNF (P = .007) and synaptophysin (P < .001) was higher than that of the CON group (Fig. 6, Table 6).

Fig. 6
figure6

Effects of exercise under exposure to the 40-Hz light flicker on BDNF, PSD95, and synaptophysin in hippocampus. CON: wild-type, AD: 3xTg-AD, AD+40: 3xTg-AD and 40-Hz light flickering, AD+EX: 3xTg-AD and exercise, and AD+40+EX: 3xTg-AD and exercise in the 40-Hz light flickering. Data are expressed as the mean ± standard error of the mean (SEM). *P < .05 compared to the CON group. #P < .05 compared to the AD group. +P < .05 compared to the AD+40+EX

Full size image
Table 6 Effect of exercise under exposure to the 40-Hz light flickering on BDNF, PSD95, and synaptophysin in the hippocampus
Full size table

Effects of exercise under exposure to the 40-Hz light flickering on cell differentiation and neurogenesis in the hippocampus

To examine cell differentiation and neurogenesis in the hippocampus, DCX-positive cells and NeuN/brdU-positive cells were examined. Compared with the CON group, DCX-positive cells and NeuN/brdU-positive cells (P < .001 respectively) in the hippocampus decreased in the AD group. In contrast, a significant increase was observed for the AD+40 (DCX-positive cells: P = .006, NeuN/brdU-positive cells: P = .002), AD+EX (DCX-positive cells: P = .001, NeuN/brdU-positive cells: P = .002), and AD+40+EX (P < .001 respectively) groups. In the comparison of the treatment groups, AD+40+EX treatment showed a significant difference compared to AD+40 and AD+EX (P < .001, respectively), while AD+40 and AD+EX treatments did not show any significant difference. It is interesting to note that the level in AD+40+EX was increased and exceed that of the CON group (DCX-positive cells: P = .004; NeuN/brdU-positive cells: P = .003). Therefore, exercise under exposure to 40-Hz light flickering was the most effective in improving cell differentiation and neurogenesis in the AD hippocampus (Fig. 7, Table 7).

Fig. 7
figure7

Effects of exercise under exposure to the 40-Hz light flicker on cell differentiation and neurogenesis in hippocampal dentate gyrus. The data are shown as the photomicrographs and data of DCX- and BrdU/NeuN-positive cells. The scale bar represents 50 μm. Mean ± standard error of the mean (SEM). CON: wild-type, AD: 3xTg-AD, AD+40: 3xTg-AD and 40-Hz light flickering, AD+EX: 3xTg-AD and exercise, and AD+40+EX: 3xTg-AD and exercise in the 40-Hz light flickering. Data are expressed as the mean ± standard error of the mean (SEM). *P < .05 compared to the CON group. #P < .05 compared to the AD group. +P < .05 compared to the AD+40+EX

Full size image
Table 7 Effect of exercise under exposure to the 40-Hz light flickering on cell differentiation and neurogenesis in the hippocampus
Full size table

Discussion

AD is an aging and neurodegenerative disorder characterized by deficits in learning, memory, and communication. AD accounts for 60 to 80% of dementia worldwide. The 3xTg AD animal model resembles the progression of cognitive and behavioral deficiencies seen in AD patients and is well suited for clinical studies of AD pathology. In this study, deficiencies in spatial learning, memory, and long-term memory were evaluated in the 3xTg AD group using the Morris Water maze and step through tests. In previous studies, 3xTg AD mice have shown loss of cognitive function and dementia-like behavioral and psychological symptoms along with in vivo long-term potentiation disorders, which are more severe in the older population [33]. This is particularly evident in the vulnerable areas of the brain, and the hippocampus is one of the most rapidly affected areas [34]. Signals that create our thoughts and memories are transmitted through nerve cells and the synapses between them. Aβ, an important protein for nerve cell growth and repair, is usually produced under physiological conditions and is excreted through the urine but when brain damage occurs, it is produced excessively and adheres to nerve cells and forms aggregates, blocking synapses, impeding the transmission of nerve signals, and causing inflammation and damage in neurons. When this occurs, memory dysfunction is a major symptom as the hippocampus and the temporal lobe are the first to develop abnormalities, which gradually spread to other areas of the brain. Altered cognitive function, including learning and memory deficits, are closely related to Aβ accumulation in the hippocampus. Aβ aggregation can cause synaptic dysfunction and neurodegeneration, which can impair cognitive function including spatial memory [35, 36]. In addition, Aβ stimulates glycogen kinase 3 (GSK3) to induce tau protein phosphorylation [37], and tau overexpression also causes an increased Aβ plaque accumulation [38]. GSK3, which promotes tau overexpression, is inhibited by phosphorylation of Ser21 by GSKα or Ser9 by GSK3β [39] and is increased in the absence of Akt activity [40]. Previous studies have shown that p-GSK3β (ser9) and p-Akt (ser473) were decreased while the expression of p-tau and Aβ increased simultaneously in the 3xTg-AD mouse [41, 42]. Aβ is closely associated with mitochondrial dysfunction, as evidenced by the accumulation of mitochondrial damage in the brains of AD patients [43], which may induce neuronal apoptosis [44], impair the movement of mitochondria, and cause synaptic degeneration by reducing mitochondrial length [45]. In the present study, the 3xTg-AD group with high Aβ expression also showed decreased mitochondrial function in the hippocampus such as decreased Ca2+ retention in hippocampal mitochondria and increased H2O2 production, a marker of reactive oxygen species (ROS). This deterioration led to an increase in cell death due to an increase in apoptosis and the expression of pro-apoptotic factors including Bax, cytochrome c, and caspase-3, as well as a decrease in the anti-apoptotic factor, Bcl-2. Cellular proliferation, neurogenesis, and synaptic markers BDNF, PSD95, and synaptophysin were also reduced in the hippocampus. Therefore, overexpression of Aβ and tau may decrease mitochondrial function, increase cell death, decrease neuron production, and reduce neuronal plasticity in the hippocampus. In previous studies, an increase in Aβ concentration resulted in increased secretion of H2O2, dysregulation of the cytosolic and mitochondrial Ca2+ homeostasis, and cytochrome c in the mitochondria [46, 47]. Particularly, mitochondrial Ca2+ overloading results in an increase of ROS production in mitochondria [48], the oxidative stress leads to abnormalities in the cell calcium storage, and the ability to control oxidative stress and respond to metabolic disorder links the AD-causing gene mutations to the disease process [49], while cell death was increased as were Bax levels with a concomitant decrease in Bcl-2 in the hippocampus of the 3xTg AD mouse, showing deficiencies in cognitive functions due to a decrease in BDNF, PSD95, and synaptophysin expression [50,51,52]. Aβ is an important pathological factor in AD. It is a neurotoxin, which can pathologically affect various brain cells. It seems that the decrease in cognitive function occurs due to inhibition of neuroplasticity following an alteration in mitochondrial function caused by excessive accumulation of Aβ and overexpression of tau in the hippocampus.

A new treatment method using LED has been recently suggested as a non-invasive therapy to treat AD. In particular, 40-Hz light flicker (LED flickers 40 times per second) is effective in stimulating the brain and restoring gamma rhythms. In an animal AD model, 40-Hz light flicker reduced p-tau and Aβ, which resolved memory abnormalities [53, 54]. Long-term visual stimulation using 40-Hz light flickering entrained gamma oscillations in the visual cortex, CA1 of the hippocampus, and the prefrontal cortex in Tau P301S and CK-p25 mice; as a result, spatial learning and memory and protein levels of various synaptic signaling and synaptic plasticity markers were improved [55]. Duan et al. [56] reported that the light from the LED inhibited apoptosis, which induces Aβ. The visual stimulation of 40-Hz light flickering has been shown to improve cognitive function by reducing neuronal and synaptic loss as well as amyloid plaques and tau phosphorylation in various AD mouse models (5XFAD, APP/PS1, P301S, and CK-p25) [50,51,52, 57]. In the present study, gamma oscillation was not measured, but in previous studies, it has been shown that the gamma oscillation in the hippocampus was altered with respect to time and concentration of Aβ [23], while the 3xTg-AD model showed synchronization of abnormal beta and gamma frequencies [58]. In the present study, the 40-Hz light flickering treatment group showed a reduction in tau phosphorylation and Aβ in the hippocampus and an improvement in spatial learning, memory, long-term memory, mitochondrial function, and neuroplasticity. This may suggest that the expression of tau and Aβ in the hippocampus was reduced by rescued gamma oscillations, which then led to an improvement in cognitive function. This may be due to the enhancement of mitochondrial function such as Ca2+ retention and ROS stabilization in the hippocampus, increased neuroplasticity such as the increase in proteins related to neurogenesis and synapses, and the inhibition of apoptosis.

Another non-invasive method to treat AD is exercise. Physical activity is known to promote brain health and improve cognitive functioning in the elderly; it has also been shown to increase hippocampal size and increase BDNF levels and neurogenesis [59, 60]. Exercise plays an important role in protecting against cognitive disorders due to dementia [61], and studies have reported low plasma Aβ and brain amyloid levels in people with low levels of physical activity [62]. In addition, in various AD animal models, exercise has been shown to delay or protect against the progression of AD by reducing Aβ and hyperphosphorylated tau protein [63,64,65,66], activating p-Akt and p-GSK3β, and reducing hyperphosphorylated tau levels [67]. As shown, exercise can play an important role in AD treatment including regulation of tau and Aβ in many of the previous studies. In addition, exercise-induced neuronal activity in the hippocampus requires increased mitochondrial capacity to produce ATP from oxidative phosphorylation of glucose. As a result, ROS may accumulate, but exercise may activate mitochondrial function and mitigate ROS-induced neurotoxins, and the protective effect of exercise against ROS production may be important in the hippocampus of patients with AD [68]. Exercise also improves hippocampal function by alleviating ROS such as H2O2 and inducing Ca2+ retention in hippocampal mitochondria under various neurotoxic conditions, and that mitochondrial function activated by exercise decreases apoptosis [69]. Furthermore, Aβ-dependent cell death is significantly suppressed after exercise in the hippocampus of an AD model [70]. In addition, exercise increases synaptic plasticity in the hippocampus, and Revilla et al. [71] found increased synaptophysin and PSD95 protein expression in the hippocampus of the 3xTg AD model.

In the present study, mitochondrial function and neuroplasticity were improved by Aβ and tau overexpression in an AD animal model through exercise as in the previous study. However, the therapeutic benefit of this in patients with AD remains controversial. Our study showed that exercise along with a non-invasive approach such as 40-Hz light flickering led to a significant improvement in AD patients, which was an important conclusion. Although much research on 40-Hz light flickering is still needed, Aβ and tau protein levels were suppressed, and the improvement in Aβ and tau expression caused by 40-Hz light flickering may have induced various positive cellular effects. Thus, under these circumstances, exercise may have a positive effect on this AD animal model as a complimentary therapy to 40-Hz light flickering.

Conclusion

Many previous studies have suggested that Aβ and tau are important pathological factors in AD pathogenesis. Abnormal expression of Aβ and tau in the hippocampus may induce a variety of changes such as decreased mitochondrial function, apoptosis, decreased neurogenesis, and reduced synaptic-related proteins, which may cause a decline in cognitive functioning. However, if gamma oscillation can be stabilized through the visual stimulation of 40-Hz light flickering, exercise may improve cognitive functioning, as these two non-invasive methods produced a synergistic effect, which improved mitochondrial function and neuroplasticity by reducing Aβ and tau levels. Further research is needed to determine the effectiveness of these non-invasive methods in various models and their clinical applications.

Availability of data and materials

All data analyzed or generated during current study are included in this published article and available from the corresponding author on reasonable request.

Abbreviations

3xTg-AD:

Triple transgenic mouse model of Alzheimer’s disease

AD:

Alzheimer’s disease

Aβ:

Amyloid beta

BDNF:

Brain-derived neurotrophic factor

BrdU:

5-Bromo-2′-deoxyuridine

DG:

Dentate gyrus

GSK3β:

Glycogen synthase 3 beta

LED:

Light-emitting diode

PSD95:

Postsynaptic density protein 95

ROS:

Reactive oxygen species

TUNEL:

Terminal deoxynucleotidyl transferase dUTP nick end labeling

References

  1. 1.

    Seshadri S, Beiser A, Selhub J, Jacques PF, Senberg IH, D’Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med. 2002;14(7):476–83.

    Article  Google Scholar 

  2. 2.

    Mattson MP. Pathways towards and away from Alzheimer’s disease. Nature. 2004;430(7000):63–9.

    Article  CAS  Google Scholar 

  3. 3.

    Swerdlow RH, Khan SM. The Alzheimer’s disease mitochondrial cascade hypothesis: an update. Exp Neurol. 2009;218(2):308–15.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  4. 4.

    Kumar A, Ekavali SA. A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep. 2015;67(2):95–203.

    Article  CAS  Google Scholar 

  5. 5.

    Wilquet V, De Strooper B. Amyloid-beta precursor protein processing in neurodegeneration. Curr Opin Neurobiol. 2004;14(5):582–8.

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Tanzi RE, Bertram L. Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell. 2005;120(4):545–55.

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Gouras GK, Almeida CG, Takahashi RH. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer’s disease. Neurobiol Aging. 2005;26(9):1235–44.

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci. 2007;8(7):499–509.

    CAS  PubMed  Article  Google Scholar 

  9. 9.

    Reddy PH, Beal MF. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer’s disease. Trends Mol Med. 2008;14(2):45–53.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  10. 10.

    Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease. Lancet. 2006;368(9533):387–403.

    CAS  PubMed  Article  Google Scholar 

  11. 11.

    Arendt T. Synaptic degeneration in Alzheimer’s disease. Acta Neuropathol. 2009;118(1):167–79.

    PubMed  Article  Google Scholar 

  12. 12.

    Stamer K, Vogel R, Thies E, Mandelkow E, Mandelkow EM. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol. 2002;156(6):1051–63.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Mandelkow EM, Stamer K, Vogel R, Thies E, Mandelkow E. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging. 2003;24(8):1079–85.

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Gibson GE, Sheu KF, Blass JP. Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neural Transm (Vienna). 1998;105(8–9):855–70.

    CAS  Article  Google Scholar 

  15. 15.

    Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer’s disease brain is associated with mitochondrial dysfunction. J Neurosci. 2006;26(35):9057–68.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  16. 16.

    Parker WD Jr, Filley CM, Parks JK. Cytochrome oxidase deficiency in Alzheimer’s disease. Neurology. 1990;40(8):1302–3.

    PubMed  Article  Google Scholar 

  17. 17.

    Valla J, Schneider L, Niedzielko T, Coon KD, Caselli R, Sabbagh MN, et al. Impaired platelet mitochondrial activity in Alzheimer’s disease and mild cognitive impairment. Mitochondrion. 2006;6(6):323–30.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  18. 18.

    Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, et al. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A. 2008;105(49):19318–23.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Ferreira AC, Castellano JM. Leaving the lights on using gamma entrainment to protect against neurodegeneration. Neuron. 2019;102(5):901–2.

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Uhlhaas PJ, Singer W. Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron. 2006;52(1):155–68.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Verret L, Mann EO, Hang GB, Barth AM, Cobos I, Ho K, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell. 2012;149(3):708–21.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  22. 22.

    Martinez-Losa M, Tracy TE, Ma K, Verret L, Clemente-Perez A, Khan AS, et al. Nav1.1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer’s disease. Neuron. 2018;98(1):75–89.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  23. 23.

    Kurudenkandy FR, Zilberter M, Biverstål H, Presto J, Honcharenko D, Strömberg R, et al. Amyloid-β-induced action potential desynchronization and degradation of hippocampal gamma oscillations is prevented by interference with peptide conformation change and aggregation. J Neurosci. 2014;34(34):11416–25.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  24. 24.

    Gray CM, König P, Engel AK, Singer W. Oscillatory responses in cat visual cortex exhibit inter-columnar synchronization which reflects global stimulus properties. Nature. 1989;338(6213):334–7.

    CAS  PubMed  Article  Google Scholar 

  25. 25.

    Buzsáki G. Rhythms of the brain. Oxford Univ Press. 2006.

  26. 26.

    Fries P, Nikolić D, Singer W. The gamma cycle. Trends Neurosci. 2007;30(7):309–16.

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Vandewalle G, Maquet P, Dijk DJ. Light as a modulator of cognitive brain function. Trends Cogn Sci. 2009;13(10):429–38.

    PubMed  Article  Google Scholar 

  28. 28.

    Naeser MA, Saltmarche A, Krengel MH, Hamblin MR, Knight JA. Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports. Photomed Laser Surg. 2011;29(50):351–8.

    PubMed  PubMed Central  Article  Google Scholar 

  29. 29.

    Adlard PA, Perreau VM, Pop V, Cotman CW. Voluntary exercise decreases amyloid load in a transgenic model of Alzheimer’s disease. J Neurosci. 2005;25(17):4217–21.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Yuede CM, Zimmerman SD, Dong H, Kling MJ, Bero AW, Holtzman DM, et al. Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer’s disease. Neurobiol Dis. 2009;35(3):426–32.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  31. 31.

    Nichol KE, Poon WW, Parachikova AI, Cribbs DH, Glabe CG, Cotman CW. Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid. J Neuroinflammation. 2008;5:13.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  32. 32.

    Leem YH, Lim HJ, Shim SB, Cho JY, Kim BS, Han PL. Repression of tau hyperphosphorylation by chronic endurance exercise in aged transgenic mouse model of tauopathies. J Neurosci Res. 2009;87(11):2561–70.

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, et al. Physical exercise protects against Alzheimer’s disease in 3xTg-AD mice. J Alzheimers Dis. 2011;24(3):421–54.

    PubMed  Article  Google Scholar 

  34. 34.

    Mu Y, Gage FH. Adult hippocampal neurogenesis and its role in Alzheimer’s disease. Mol Neurodegener. 2011;6:85.

    PubMed  PubMed Central  Article  Google Scholar 

  35. 35.

    Jo J, Whitcomb DJ, Olsen KM, Kerrigan TL, Lo SC, Bru-Mercier G, et al. Aβ (1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β. Nat Neurosci. 2011;14(5):545–7.

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Yuan L, Liu XJ, Han WN, Li QS, Wang ZJ, Wu MN, et al. [Gly14]-Humanin protects against amyloid β peptide-induced impairment of spatial learning and memory in rats. Neurosci Bull. 2016;32(4):374–82.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Hernández F, Gómez de Barreda E, Fuster-Matanzo A, Lucas JJ, Avila J. GSK3: a possible link between beta amyloid peptide and tau protein. Exp Neurol. 2010;223(2):322–5.

    PubMed  Article  CAS  Google Scholar 

  38. 38.

    Bright J, Hussain S, Dang V, Wright S, Cooper B, Byun T, et al. Human secreted tau increases amyloid-beta production. Neurobiol Aging. 2015;36(2):693–709.

    CAS  PubMed  Article  Google Scholar 

  39. 39.

    Jope RS, Johnson GV. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci. 2004;29(2):95–102.

    CAS  PubMed  Article  Google Scholar 

  40. 40.

    Townsend M, Mehta T, Selkoe DJ. Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem. 2007;282(46):33305–12.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  41. 41.

    Chen Y, Liang Z, Tian Z, Blanchard J, Dai CL, Chalbot S, et al. Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice. Mol Neurobiol. 2014;49(1):547–62.

    CAS  PubMed  Article  Google Scholar 

  42. 42.

    Li T, Jiao JJ, Hölscher C, Wu MN, Zhang J, Tong JQ, et al. A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer’s disease. Hippocampus. 2018;28(5):358–72.

    CAS  PubMed  Article  Google Scholar 

  43. 43.

    Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer’s disease. Science. 2004;304(5669):448–52.

    CAS  PubMed  Article  Google Scholar 

  44. 44.

    Awasthi A, Matsunaga Y, Yamada T. Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides. Exp Neurol. 2005;196(2):282–9.

    CAS  PubMed  Article  Google Scholar 

  45. 45.

    Calkins MJ, Reddy PH. Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer’s disease neurons. Biochim Biophys Acta. 2011;1812(4):507–13.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  46. 46.

    Aleardi AM, Benard G, Augereau O, Malgat M, Talbot JC, Mazat JP, et al. Gradual alteration of mitochondrial structure and function by beta-amyloids: importance of membrane viscosity changes, energy deprivation, reactive oxygen species production, and cytochrome c release. J Bioenerg Biomembr. 2005;37(4):207–25.

    CAS  PubMed  Article  Google Scholar 

  47. 47.

    Eckert A, Keil U, Marques CA, Bonert A, Frey C, Schüssel K, Müller WE. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer’s disease. Biochem Pharmacol. 2003;66(8):1627–34.

    CAS  PubMed  Article  Google Scholar 

  48. 48.

    Du H, Yan SS. Mitochondrial permeability transition pore in Alzheimer’s disease: cyclophilin D and amyloid beta. Biochim Biophys Acta. 2010;1802(1):198–204.

    CAS  PubMed  Article  Google Scholar 

  49. 49.

    Gibson GE. Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer’s disease. Free Radic Biol Med. 2002;32(11):1061–70.

    CAS  PubMed  Article  Google Scholar 

  50. 50.

    Corona C, Masciopinto F, Silvestri E, Viscovo AD, Lattanzio R, Sorda RL, et al. Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction. Cell Death Dis. 2010;21:e91.

    Article  CAS  Google Scholar 

  51. 51.

    Hedberg MM, Clos MV, Ratia M, Gonzalez D, Lithner CU, Camps P, et al. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice. Neurodegener Dis. 2010;7(6):379–88.

    PubMed  Article  Google Scholar 

  52. 52.

    Hu Y, Lai J, Wan B, Liu X, Zhang Y, Zhang J, et al. Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice. Neurotoxicology. 2016;53:290–300.

    CAS  PubMed  Article  Google Scholar 

  53. 53.

    Iaccarino HF, Singer AC, Martorell AJ, Rudenko A, Gao F, Gillingham TZ, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016;540(7632):230–5.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  54. 54.

    Singer AC, Martorell AJ, Douglas JM, Abdurrob F, Attokaren MK, Tipton J, et al. Noninvasive 40-Hz light flicker to recruit microglia and reduce amyloid beta load. Nat Protoc. 2018;13(8):1850–68.

    CAS  PubMed  Article  Google Scholar 

  55. 55.

    Adaikkan C, Middleton SJ, Marco A, Pao PC, Mathys H, Kim DN, et al. Gamma entrainment binds higher-order brain regions and offers neuroprotection. Neuron. 2019;102(5):929–43.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  56. 56.

    Duan R, Zhu L, Liu TC, Li Y, Liu J, Jiao J, et al. Light emitting diode irradiation protect against the amyloid beta 25-35 induced apoptosis of PC12 cell in vitro. Lasers Surg Med. 2003;33(3):199–203.

    PubMed  Article  Google Scholar 

  57. 57.

    Martorell AJ, Paulson AL, Suk HJ, Abdurrob F, Drummond GT, Guan W, et al. Multi-sensory gamma stimulation ameliorates Alzheimer’s-associated pathology and improves cognition. Cell. 2019;177(2):256–71.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  58. 58.

    Castano-Prat P, Perez-Mendez L, Perez-Zabalza M, Sanfeliu C, Giménez-Llort L, Sanchez-Vives MV. Altered slow (<1 Hz) and fast (beta and gamma) neocortical oscillations in the 3xTg-AD mouse model of Alzheimer’s disease under anesthesia. Neurobiol Aging. 2019;79:142–51.

    PubMed  Article  Google Scholar 

  59. 59.

    Boehme F, Gil-Mohapel J, Cox A, Patten A, Giles E, Brocardo PS, et al. Voluntary exercise induces adult hippocampal neurogenesis and BDNF expression in a rodent model of fetal alcohol spectrum disorders. Eur J Neurosci. 2011;33(10):1799–1811.

    PubMed  Article  Google Scholar 

  60. 60.

    Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, et al. Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A. 2011;108(7):3017–22.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  61. 61.

    Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, Crane P, et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med. 2006;144(2):73–81.

    PubMed  Article  Google Scholar 

  62. 62.

    Brown BM, Peiffer JJ, Taddei K, Lui JK, Laws SM, Gupta VB, et al. Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Mol Psychiatry. 2013;18(8):875–81.

    CAS  PubMed  Article  Google Scholar 

  63. 63.

    Ohia-Nwoko O, Montazari S, Lau YS, Eriksen JL. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice. Mol Neurodegener. 2014;9:54.

    PubMed  PubMed Central  Article  Google Scholar 

  64. 64.

    Cho J, Shin MK, Kim D, Lee I, Kim S, Kang H. Treadmill running reverses cognitive declines due to Alzheimer disease. Med Sci Sports Exerc. 2015;47(9):1814–24.

    CAS  PubMed  Article  Google Scholar 

  65. 65.

    Zhang J, Guo Y, Wang Y, Song L, Zhang R, Du Y. Long-term treadmill exercise attenuates Aβ burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer’s disease. Neurosci Lett. 2018;666:70–7.

    CAS  PubMed  Article  Google Scholar 

  66. 66.

    Kim D, Cho J, Kang H. Protective effect of exercise training against the progression of Alzheimer’s disease in 3xTg-AD mice. Behav Brain Res. 2019;374:112105.

    CAS  PubMed  Article  Google Scholar 

  67. 67.

    Kim D, Cho J, Lee I, Jin Y, Kang H. Exercise attenuates high-fat diet-induced disease progression in 3xTg-AD mice. Med Sci Sports Exerc. 2017;49(4):676–86.

    PubMed  Article  Google Scholar 

  68. 68.

    Intlekofer KA, Cotman CW. Exercise counteracts declining hippocampal function in aging and Alzheimer’s disease. Neurobiol Dis. 2013;57:47–55.

    CAS  PubMed  Article  Google Scholar 

  69. 69.

    Park HS, Kim CJ, Kwak HB, No MH, Heo JW, Kim TW. Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain. Neuropharmacology. 2018;133:451–61.

    CAS  PubMed  Article  Google Scholar 

  70. 70.

    Um HS, Kang EB, Koo JH, Kim HT, Jin-Lee KEJ, et al. Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer’s disease. Neurosci Res. 2011;69(2):161–73.

    CAS  PubMed  Article  Google Scholar 

  71. 71.

    Revilla S, Suñol C, García-Mesa Y, Giménez-Llort L, Sanfeliu C, Cristòfol R. Physical exercise improves synaptic dysfunction and recovers the loss of survival factors in 3xTg-AD mouse brain. Neuropharmacology. 2014;81:55–63.

    CAS  PubMed  Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2017S1A5B5A02025250).

Author information

Author notes

  1. Sang-Seo Park and Hye-Sang Park contributed equally to this work.

Affiliations

  1. Department of Physiology, College of Medicine, KyungHee University, Seoul, Republic of Korea

    Sang-Seo Park, Chang-Ju Kim & Tae-Woon Kim

  2. Department of Kinesiology, College of Public Health and Cardiovascular Research Center, Lewis Katz school of Medicine, Temple University, Philadelphia, PA, USA

    Hye-Sang Park

  3. College of Sports science, Sungkyunkwan University, Suwon, Republic of Korea

    Hyun-Sik Kang & Dong-Hyun Kim

  4. Department of Exercise & Health Science, Exercise Rehabilitation Research Institute, Sangmyung University, Seoul, Republic of Korea

    Seung-Soo Baek & Tae-Woon Kim

Authors
  1. Sang-Seo Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hye-Sang Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chang-Ju Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hyun-Sik Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dong-Hyun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seung-Soo Baek
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tae-Woon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S-S P and H-S P did the data acquisition, data analysis, writing of original draft, and project administration resources. C-J K and H-S K did the supervision, review, and editing. D-H K did the data acquisition. S-S B did the review and editing. T-W K did the conceptualization, data acquisition, funding acquisition, project administration resources, supervision, writing, review, and editing. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Tae-Woon Kim.

Ethics declarations

Ethics approval and consent to participate

All animal experiments were performed in accordance with the guidelines of the National Institutes of Health and the Korean Academy of Medical Science. The study protocol was approved by the KyungHee University Institutional Animal Care and Use Committee (approval number KHUASP [SE]-17-103).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Park, SS., Park, HS., Kim, CJ. et al. Physical exercise during exposure to 40-Hz light flicker improves cognitive functions in the 3xTg mouse model of Alzheimer’s disease. Alz Res Therapy 12, 62 (2020). https://doi.org/10.1186/s13195-020-00631-4

Download citation

Keywords

  • Alzheimer’s disease
  • Exercise
  • Amyloid beta
  • Tau
  • 40-Hz light flicker
  • Cognitive function
  • Mitochondria
  • Apoptosis
  • Neuroplasticity
  • Hippocampus

Alzheimer's Research & Therapy

ISSN: 1758-9193

\